Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study

BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are novel agents used to treat type 2 diabetic patients. We investigated the efficacy of the SGLT2 inhibitor ipragliflozin on diabetic nephropathy in Japanese patients with type 2 diabetes. METHODS: A 50 mg dose of ipragliflozin was admin...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:J Clin Med Res
Main Authors: Ito, Daisuke, Ikuma-Suwa, Emi, Inoue, Kazuyuki, Kaneko, Kimie, Yanagisawa, Morifumi, Inukai, Kouichi, Noda, Mitsuhiko, Shimada, Akira
Formáid: Artigo
Teanga:Inglês
Foilsithe: Elmer Press 2017
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215019/
https://ncbi.nlm.nih.gov/pubmed/28090231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2875w
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla